VARIABLE < 92 mg/dL (n=59) 93-122 mg/dL (n=59) > 123 mg/dL (n=58) P
LDL-C 71 (61, 82) 106 (100, 115) 144 (132, 160) < 0.001
Triglycerides 128 (81, 237) 146 (84, 250) 126 (85, 188) 0.57
RLP-C 7.9 (5.4, 18.8) 10.3 (6.6, 18.6) 8.8 (7.1, 14.7) 0.44
NEFA (mEq/L) 0.3 (0.3, 0.4) 0.4 (0.2, 0.5) 0.3 (0.2, 0.5) 0.97
Apo-B 65 (52, 80) 86 (76, 94) 98 (92, 107) < 0.001
Lp(a) 15 (6, 30) 15 (5, 40) 26 (15, 59) 0.006
HDL-C 33 (25, 48) 36 (31, 46) 42 (33, 49) 0.013
HDL-TG 18 (14, 25) 18 (11, 28) 14 (10, 19) 0.039
ApoA-I 118 (98, 142) 126 (108, 139) 125 (111, 141) 0.29
ApoA-II 33 (27, 41) 33 (30, 40) 37 (29, 43) 0.23
ApoE 4.0 (3.3, 5.3) 4.3 (3.4, 5.3) 4.2 (3.5, 5.5) 0.76
Preβ-1 35 (24, 46) 39 (32, 46) 35 (29, 43) 0.30
Preβ-2 1.5 (0.9, 2.8) 1.5 (1.0, 2.6) 2.1 (1.2, 3.5) 0.094
α-1 10 (5, 17) 10 (7, 17) 10 (6, 14) 0.86
α-2 26 (22, 32) 30 (25, 39) 28 (23, 35) 0.13
α-3 22 (17, 28) 23 (18, 27) 23 (18, 30) 0.83
α-4 7 (5, 10) 7 (5, 9) 8 (6, 10) 0.94
Preα-1 2.3 (0.6, 6.2) 2.6 (0.8, 5.1) 2.5 (1.2, 4.1) 0.93
Preα-2 3.4 (2.1, 4.6) 4.1 (2.3, 5.7) 3.8 (2.7, 5.2) 0.50
Preα-3 2.9 (2.1, 4.0) 2.8 (1.9, 3.8) 2.8 (2.1, 4.5) 0.68
Preα-4 1.2 (0.7, 1.5) 1.2 (0.6, 1.7) 1.1 (0.5, 1.7) 0.82
CETP (μg/mL) 2.0 (1.7, 2.5) 2.2 (1.7, 2.6) 2.3 (2.0, 2.8) 0.050
LCAT (μg/mL) 7 (6, 8) 7 (6, 8) 7 (6, 9) 0.42
CETP Activity (μg/mL/hour) -0.1 (-1.3, 1.8) 0.9 (-0.3, 2.7) 0.2 (-0.9, 1.8) 0.17
LCAT Activity (μg/mL/hour) 17 (11, 26) 18 (11, 27) 14 (8, 27) 0.41
Table 3b: Lipoprotein-associated parameters in patients, divided by LDL-C level.